Valuation: Novartis AG

Market Cap 297B 261B 243B 223B 418B 28,599B 425B 2,880B 1,125B 14,060B 1,115B 1,091B 48,614B P/E 2026 *
21.7x
P/E 2027 * 18.7x
Enterprise Value 330B 290B 270B 247B 465B 31,795B 472B 3,202B 1,251B 15,632B 1,239B 1,213B 54,047B EV / Sales 2026 *
5.74x
EV / Sales 2027 * 5.32x
Free-Float
91.66%
Yield 2026 *
2.8%
Yield 2027 * 2.92%
1 day-0.67%
1 week+1.52%
Current month+0.25%
1 month+2.06%
3 months+11.61%
6 months+9.51%
Current year+15.78%
1 week 121.68
Extreme 121.68
127.98
1 month 121.06
Extreme 121.06
128.92
Current year 107.68
Extreme 107.68
131
1 year 91.56
Extreme 91.56
131
3 years 81.1
Extreme 81.1
131
5 years 72.84
Extreme 72.84
131
10 years 65.09
Extreme 65.09
131
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Chief Tech/Sci/R&D Officer 64 16/05/2022
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
18/05/26 Sell -5,200 0.0003%
04/05/26 Sell 6,800 0.0003%
17/02/26 Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-0.60%+1.52%+35.68%+39.76% 297B
+0.81%+1.73%+48.93%+161.16% 1,057B
+1.21%+3.70%+54.75%+53.37% 624B
+0.59%+1.62%+35.52%+80.62% 454B
+1.60%+6.25%+33.95%+29.84% 341B
-0.14%+0.60%+16.17%+17.53% 262B
+0.09%-2.82%-28.29%-41.71% 215B
+1.22%+2.83%+22.08%+60.00% 201B
-0.61%-3.22%+14.80%+67.34% 162B
+0.06%-1.76%-2.94%-34.40% 143B
Average +0.49%+0.64%+23.07%+43.35% 375.65B
Weighted average by Cap. +0.68%+1.49%+34.28%+73.47%

Financials

2026 *2027 *
Net sales 57.51B 50.51B 46.98B 43.11B 81B 5,539B 82.24B 558B 218B 2,723B 216B 211B 9,415B 60.99B 53.57B 49.82B 45.71B 85.89B 5,873B 87.22B 592B 231B 2,888B 229B 224B 9,984B
Net income 13.97B 12.27B 11.41B 10.47B 19.67B 1,345B 19.98B 135B 52.94B 661B 52.44B 51.31B 2,287B 15.64B 13.73B 12.77B 11.72B 22.02B 1,506B 22.36B 152B 59.25B 740B 58.7B 57.43B 2,560B
Net Debt 33.19B 29.15B 27.11B 24.87B 46.74B 3,196B 47.46B 322B 126B 1,571B 125B 122B 5,433B 27.45B 24.11B 22.42B 20.58B 38.66B 2,644B 39.26B 266B 104B 1,300B 103B 101B 4,494B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
24/07/26 CHF 126.90 -0.60% 1,859,367
23/07/26 CHF 127.66 +1.85% 2,482,939
22/07/26 CHF 125.34 -0.16% 2,648,334
21/07/26 CHF 125.54 +1.98% 3,462,607
20/07/26 CHF 123.10 -1.52% 1,700,014
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
156.25USD
Average target price
153.66USD
Spread / Average Target
-1.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock